Infliximab in the treatment of ulcerative colitis with toxic megacolon

Parupudi V.J. Sriram, K. S.Pavan Reddy, Guduru V. Rao, Darisetty Santosh, Duvvuru Nageshwar Reddy

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Toxic megacolon is a gastrointestinal emergency requiring prompt management to avoid fatal outcome. Although a majority of patients respond to conservative treatment, those not responding have been treated with intravenous cyclosporine or emergency surgery. Infliximab has been tried in patients with severe steroid-refractory ulcerative colitis. We report the successful use of this drug in the management of toxic megacolon in a 48-year-old woman not responding to the routine measures and who refused surgery.

Original languageEnglish (US)
Pages (from-to)22-23
Number of pages2
JournalIndian Journal of Gastroenterology
Volume23
Issue number1
StatePublished - Jan 1 2004
Externally publishedYes

Keywords

  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Infliximab in the treatment of ulcerative colitis with toxic megacolon'. Together they form a unique fingerprint.

  • Cite this

    Sriram, P. V. J., Reddy, K. S. P., Rao, G. V., Santosh, D., & Reddy, D. N. (2004). Infliximab in the treatment of ulcerative colitis with toxic megacolon. Indian Journal of Gastroenterology, 23(1), 22-23.